Browse > Article
http://dx.doi.org/10.14776/piv.2019.26.e15

Intraventricular Vancomycin Therapy for Intractable Bacillus cereus Ventriculitis  

Hahn, Jong Woo (Department of Pediatrics, Seoul National University College of Medicine)
Ju, Hee young (Center for Pediatric Cancer, National Cancer Center)
Park, Meerim (Center for Pediatric Cancer, National Cancer Center)
Yi, Eun Sang (Department of Pediatrics, Korea University Guro Hospital, Korea University College of Medicine)
Park, Byung-Kiu (Center for Pediatric Cancer, National Cancer Center)
Shin, Sang-Hoon (Neuro-Oncology Clinic, National Cancer Center)
Lee, Sang-Hyun (Department of Radiology, National Cancer Center)
Park, Hyeon Jin (Center for Pediatric Cancer, National Cancer Center)
Kang, Ji-Man (Center for Pediatric Cancer, National Cancer Center)
Publication Information
Pediatric Infection and Vaccine / v.26, no.2, 2019 , pp. 124-128 More about this Journal
Abstract
Bacillus cereus causes serious central nervous system infections, especially in immunocompromised patients. Successful treatment requires adequate antimicrobial concentrations in the cerebrospinal fluid; however, in some cases, achieving this with systemic treatment alone is difficult. We treated intractable B. cereus ventriculitis with intraventricular vancomycin, with no major adverse events.
Keywords
Bacillus cereus; Injections, intraventricular; Central nervous system infection; Vancomycin; Pharmacokinetics; Cerebral ventriculitis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Scheld WM, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis 2017;64:e34-65.   DOI
2 Gaur AH, Patrick CC, McCullers JA, Flynn PM, Pearson TA, Razzouk BI, et al. Bacillus cereus bacteremia and meningitis in immunocompromised children. Clin Infect Dis 2001;32:1456-62.   DOI
3 Nau R, Sorgel F, Eiffert H. Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev 2010;23:858-83.   DOI
4 Uchino Y, Iriyama N, Matsumoto K, Hirabayashi Y, Miura K, Kurita D, et al. A case series of Bacillus cereus septicemia in patients with hematological disease. Intern Med 2012;51:2733-8.   DOI
5 Stevens MP, Elam K, Bearman G. Meningitis due to Bacillus cereus: a case report and review of the literature. Can J Infect Dis Med Microbiol 2012;23:e16-9.   DOI